SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)

SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪14.33 B‬CNY
5.34CNY
‪492.43 M‬CNY
‪1.18 B‬CNY
‪67.18 M‬
Beta (1Y)
1.55
Employees (FY)
908
Change (1Y)
+122 +15.52%
Revenue / Employee (1Y)
‪1.29 M‬CNY
Net income / Employee (1Y)
‪542.33 K‬CNY

About SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)


CEO
Qing Zhu
Headquarters
Shanghai
Founded
2012
ISIN
CNE100003MJ5
FIGI
BBG00NW4YMQ1
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, production, and sale of aortic and peripheral vascular interventional medical devices. Its products include thoracic aortic stent system, abdominal aortic stent system, intraoperative stent system, and peripheral artery interventional product. The company was founded on August 17, 2012 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 688016 is 119.26 CNY — it has increased by 2.43% in the past 24 hours. Watch SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) stocks are traded under the ticker 688016.
688016 stock has risen by 4.55% compared to the previous week, the month change is a 10.27% rise, over the last year SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) has showed a −3.70% decrease.
We've gathered analysts' opinions on SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) future price: according to them, 688016 price has a max estimate of 150.00 CNY and a min estimate of 86.00 CNY. Watch 688016 chart and read a more detailed SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) stock forecast: see what analysts think of SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) and suggest that you do with its stocks.
688016 reached its all-time high on Jul 5, 2021 with the price of 322.15 CNY, and its all-time low was 67.79 CNY and was reached on Jul 22, 2019. View more price dynamics on 688016 chart.
See other stocks reaching their highest and lowest prices.
688016 stock is 2.74% volatile and has beta coefficient of 1.55. Track SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) there?
Today SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) has the market capitalization of ‪14.57 B‬, it has increased by 1.99% over the last week.
Yes, you can track SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) financials in yearly and quarterly reports right on TradingView.
SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
688016 earnings for the last quarter are 1.22 CNY per share, whereas the estimation was 1.50 CNY resulting in a −18.87% surprise. The estimated earnings for the next quarter are 1.21 CNY per share. See more details about SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) earnings.
SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) revenue for the last quarter amounts to ‪182.00 M‬ CNY, despite the estimated figure of ‪376.04 M‬ CNY. In the next quarter, revenue is expected to reach ‪534.59 M‬ CNY.
688016 net income for the last quarter is ‪149.81 M‬ CNY, while the quarter before that showed ‪219.23 M‬ CNY of net income which accounts for −31.66% change. Track more SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) financial stats to get the full picture.
SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) dividend yield was 1.54% in 2023, and payout ratio reached 50.40%. The year before the numbers were 1.22% and 46.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 908.00 employees. See our rating of the largest employees — is SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) on this list?
Like other stocks, 688016 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) stock shows the buy signal. See more of SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.